Advisor Net Financial, Inc Fate Therapeutics Inc Transaction History

Advisor Net Financial, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$9.86 - $23.83 $3,648 - $8,817	-370 Reduced 78.72%	100 $0
Q1 2021 Apr 14, 2021	SELL	$72.16 - $117.4 $7,216 - $11,740	-100 Reduced 17.54%	470 $39,000
Q4 2020 Feb 04, 2021	BUY	$38.09 - $100.95 $9,903 - $26,247	260 Added 83.87%	570 $52,000
Q1 2020 May 14, 2020	BUY	$17.28 - $31.88 $5,356 - $9,882	310 New	310 $7,000

167

108M

79.2K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $138M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.